Thrivent Financial for Lutherans Has $1.65 Million Holdings in Acadia Healthcare Company, Inc. $ACHC

Thrivent Financial for Lutherans lifted its stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 207.2% in the 3rd quarter, HoldingsChannel.com reports. The fund owned 66,622 shares of the company’s stock after acquiring an additional 44,932 shares during the period. Thrivent Financial for Lutherans’ holdings in Acadia Healthcare were worth $1,650,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in the stock. Allworth Financial LP boosted its position in Acadia Healthcare by 676.4% during the second quarter. Allworth Financial LP now owns 1,351 shares of the company’s stock worth $31,000 after purchasing an additional 1,177 shares during the period. EverSource Wealth Advisors LLC boosted its holdings in shares of Acadia Healthcare by 54.8% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock worth $32,000 after buying an additional 497 shares during the period. CWM LLC grew its stake in Acadia Healthcare by 105.1% in the 2nd quarter. CWM LLC now owns 2,633 shares of the company’s stock valued at $60,000 after buying an additional 1,349 shares during the last quarter. Quent Capital LLC bought a new position in Acadia Healthcare in the 3rd quarter worth $71,000. Finally, Steward Partners Investment Advisory LLC lifted its position in Acadia Healthcare by 639.5% during the 2nd quarter. Steward Partners Investment Advisory LLC now owns 3,372 shares of the company’s stock worth $77,000 after acquiring an additional 2,916 shares during the last quarter.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on the company. Barclays dropped their price objective on Acadia Healthcare from $17.00 to $14.00 and set an “equal weight” rating on the stock in a research note on Thursday, December 4th. Weiss Ratings reiterated a “sell (d)” rating on shares of Acadia Healthcare in a report on Wednesday, January 21st. Bank of America downgraded shares of Acadia Healthcare from a “neutral” rating to an “underperform” rating and lowered their price objective for the stock from $21.50 to $13.00 in a research note on Wednesday, December 3rd. Guggenheim cut their target price on shares of Acadia Healthcare from $29.00 to $27.00 and set a “buy” rating for the company in a research note on Monday, November 10th. Finally, Jefferies Financial Group lowered shares of Acadia Healthcare to a “hold” rating in a research report on Thursday, January 22nd. Six investment analysts have rated the stock with a Buy rating, six have given a Hold rating and three have issued a Sell rating to the company’s stock. Based on data from MarketBeat, Acadia Healthcare presently has an average rating of “Hold” and a consensus price target of $18.62.

Acadia Healthcare Stock Up 2.3%

Shares of ACHC stock opened at $15.89 on Friday. Acadia Healthcare Company, Inc. has a one year low of $11.43 and a one year high of $42.85. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.44 and a quick ratio of 1.44. The stock has a fifty day moving average price of $13.94 and a 200 day moving average price of $18.76. The stock has a market cap of $1.47 billion, a P/E ratio of 13.58, a price-to-earnings-growth ratio of 4.42 and a beta of 0.89.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.